Cara Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cara Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q2 2024.
  • Cara Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 54.8M shares, a 1.42% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 54.8M +769K +1.42% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 54.7M +693K +1.28% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 54.5M +683K +1.27% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 54.5M +738K +1.37% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 54.1M +359K +0.67% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 54M +383K +0.72% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 53.8M +317K +0.59% Dec 31, 2022 10-K 2024-03-06
Q3 2022 53.7M +3.56M +7.09% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 53.7M +3.62M +7.23% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 53.6M +3.56M +7.13% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 53.5M +3.61M +7.24% Dec 31, 2021 10-K 2023-03-06
Q3 2021 50.2M +3.28M +7% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 50.1M +3.22M +6.88% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 50M +3.3M +7.06% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 49.9M +3.15M +6.75% Dec 31, 2020 10-K 2022-03-01
Q3 2020 46.9M +219K +0.47% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 46.9M +6.84M +17.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 46.7M +7.15M +18.1% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 46.7M +7.17M +18.1% Dec 31, 2019 10-K 2021-02-25
Q3 2019 46.7M +7.28M +18.5% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 40M +5.97M +17.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 39.6M +6.88M +21% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 39.5M +6.89M +21.1% Dec 31, 2018 10-K 2020-02-27
Q3 2018 39.4M +6.78M +20.8% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 34.1M +1.49M +4.58% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 32.7M +5.38M +19.7% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 32.7M +5.37M +19.7% Dec 31, 2017 10-K 2019-03-12
Q3 2017 32.6M +5.33M +19.5% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 32.6M +5.28M +19.4% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 27.3M +41.3K +0.15% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 27.3M +42K +0.15% Dec 31, 2016 10-K 2018-03-15
Q3 2016 27.3M +51.3K +0.19% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 27.3M +4.45M +19.5% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 27.3M +4.46M +19.5% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 27.3M +4.45M +19.5% Dec 31, 2015 10-K 2017-03-10
Q3 2015 27.2M +4.45M +19.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 22.8M +199K +0.88% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 22.8M +233K +1.03% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 22.8M +18.5M +432% Dec 31, 2014 10-K 2016-03-11
Q3 2014 22.8M Sep 30, 2014 10-Q 2014-11-10
Q2 2014 22.6M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 22.6M Mar 31, 2014 10-Q 2014-05-12
Q4 2013 4.29M Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.